Skip to main content

UBS Group AG

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in RCKT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$4,647,458
+$4,115,933 QoQ
Shares Held
1,298,173
+757.3% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in RCKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. RCKT ranks #153 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RCKT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,647,458 1,298,173
2025-12-31 $531,525 151,432
2025-09-30 $1,737,552 532,992
2025-06-30 $2,049,444 836,508
2025-03-31 $4,321,025 647,830
2024-12-31 $7,164,434 569,963
2024-09-30 $6,245,333 338,134
2024-06-30 $8,736,486 405,782
2024-03-31 $13,711,219 508,954
2023-12-31 $1,282,835 42,804
2023-09-30 $5,291,111 258,229
2023-06-30 $544,775 27,417
2023-03-31 $1,989,717 116,154
2022-12-31 $5,778,257 295,261
2022-09-30 $1,546,571 96,903
2022-06-30 $918,988 66,787
2022-03-31 $2,762,763 174,197
2021-12-31 $3,072,178 140,732
2021-09-30 $2,866,539 95,903
2021-06-30 $538,610 12,161
2021-03-31 $3,292,830 74,213
2020-12-31 $2,531,687 46,165
2020-09-30 $461,176 20,174
2020-06-30 $63,794 3,048
2020-03-31 $424,191 30,408